Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Parkinson’s disease biomarkers based on α‐synuclein

2 Jul 2019

Abstract excerpt

Parkinson's disease is the second most common neurodegenerative disorder after Alzheimer's disease and is estimated to affect approximately 1-4% of individuals aged over 60 years old. Although considerable efforts have been invested into developing disease-modifying therapies for Parkinson's disease, such efforts have been confounded by the difficulty in accurately diagnosing Parkinson's disease during life to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Botulinum Toxin and Related Neurological Disorders
Share to Neurological disorders and treatments
Share to Parkinson's Disease Mechanisms and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31265130
DOI: 10.1111/jnc.14809

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Parkinson’s disease biomarkers based on α‐synucleinPMID 31265130Read ↗

Methods for detecting toxic α-synuclein species as a biomarker for Parkinson’s diseaseSemantic proximity Read ↗

Navigating the Neurobiology of Parkinson’s: The Impact and Potential of α-SynucleinSemantic proximity Read ↗

Alpha-synuclein is increased in erythrocytes in Parkinson’s Disease casesSemantic proximity Read ↗

Cerebrospinal Fluid Biomarker Candidates for Parkinsonian DisordersSemantic proximity Read ↗

Alterations of Erythrocytic Phosphorylated Alpha-Synuclein in Different Subtypes and Stages of Parkinson's DiseaseSemantic proximity Read ↗

Combined measure of salivary alpha-synuclein species as diagnostic biomarker for Parkinson’s diseaseSemantic proximity Read ↗

AlphaLISA detection of alpha-synuclein in the cerebrospinal fluid and its potential application in Parkinson’s disease diagnosisSemantic proximity Read ↗

Alpha-Synuclein Aggregation in Parkinson's DiseaseSemantic proximity Read ↗

Alpha-Synuclein in Parkinson’s Disease: From Pathogenetic Dysfunction to Potential Clinical ApplicationSemantic proximity Read ↗

Diagnostic biomarkers for Parkinson's disease at a glance: where are we?Semantic proximity Read ↗

Aggregated α-synuclein in erythrocytes as a potential biomarker for idiopathic Parkinson's DiseaseSemantic proximity Read ↗

From phenotype to biology: a multi-modal roadmap of biofluid, tissue, imaging, and digital biomarkers in Parkinson's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.